Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazumasa Hara
Clinical Study of Long-Term Docetaxel Based Chemotherapy Treatment for Patients With Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
The Evaluation of Four Scoring Systems for Critical Care During Acute Blood Purification Therapy
Nihon Toseki Igakkai Zasshi
Related publications
Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review
European Oncology and Haematology
Oncology
Hematology
Pcn336 - Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Previously Treated With Docetaxel in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cabazitaxel in the Management of Metastatic Castration-Resistant Prostate Cancer Progressing After Docetaxel-Based Chemotherapy
European Oncology and Haematology
Oncology
Hematology
Outcome of Combination Chemotherapy With Docetaxel, Estramustine Phosphate, and Carboplatin After Docetaxel and Prednisolone Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer
Journal of Cancer Therapy
Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel
Japanese Journal of Urology
Urology
Guideline Adherence in Docetaxel Treatment of Castration Resistant Prostate Cancer (CRPC) Patients in a Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Castration-Dependent Pharmacokinetics of Docetaxel in Patients With Prostate Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Predictors of Long-Term Response to Abiraterone in Patients With Metastastic Castration-Resistant Prostate Cancer: A Retrospective Cohort Study
Oncotarget
Oncology
